DESCRIPTIVE STUDY OF NON-PROLIFERATIVE CORRELATED WITH PROLIFERATIVE DIABETIC RETINOPATHY IN CLINICAL HOSPITAL SHTIP

Authors

  • Strahil Gazepov University ,Goce Delchev, Shtip N. Macedonia
  • Doruntina Selimi Ademi University ,Goce Delchev, Shtip N.Macedonia
  • Eleonora Grozdanova University ,Goce Delchev, Shtip N.Macedonia
  • Biljana Gjorgieva University ,Goce Delchev, Shtip N.Macedonia
  • Toni Shekerinov University ,Goce Delchev, Shtip N.Macedonia

Keywords:

diabetic retinopathy, diabetes mellitus, prevention, treatment

Abstract

Diabetes is the leading cause of reduced vision in the world's working-age population, equally represented
in men and women, which if not treated, can lead to blindness. Diabetes can cause damage to the eyes as a result of
long-term increased blood sugar levels. It damages the blood vessels of the retina, there is bleeding on the retina
itself, swelling and fatty deposits especially in the center for clear vision, as well as the creation of new blood
vessels. Newly formed blood vessels have weak and abnormal walls, so they burst and bleed, which is why bleeding
occurs inside the eye. This condition is called diabetic retinopathy. The longer you have diabetes , the more likely
you are to develop this eye complication. Other risk factors for the occurrence of diabetic retinopathy besides
unregulated glycemia are hypertension, dyslipidemia, abdominal obesity, anemia, diabetic nephropathy, family
history of diabetic retinopathy, pregnancy. Symptoms of diabetic retinopathy include gradual deterioration of
vision, blurred vision, sudden loss of vision, appearance of flies in the field of vision - opacities, pain in the eyes. It
is clinically diagnosed and classified according to vascular changes in the fundus.
There are two types of diabetic retinopathy: Early diabetic retinopathy - more commonly called non-proliferative
diabetic retinopathy. Advanced Diabetic Retinopathy - Diabetic retinopathy can progress to this more severe type,
known as proliferative diabetic retinopathy. A study showed that in patients with type 1 diabetes, in the first 5 years
after diagnosis, they will develop non-proliferative retinopathy in a smaller percentage 5%, after 20 years from the
diagnosis, this percentage will be 80%. Of the total number of patients with type 1 diabetes, 15-40% will develop
proliferative retinopathy after 20 years. Unlike type 1 diabetes, patients with type 2 diabetes develop proliferative
retinopathy in a much smaller percentage: 10% of those treated with diet and oral antidiabetic drugs and 20% of
those treated with insulin.
Diabetes is on the rise and has an almost epidemic progression that will affect more than 700 million people
worldwide by 2045. The increasing prevalence of diabetes affects young people as well as adults, with the number
of young people with type 1 diabetes (T1D) predicted to increase almost 3-fold and those with type 2 diabetes (T2D)
to almost quadruple to 2050. The best treatment for diabetic retinopathy is prevention. You can't always prevent
diabetic retinopathy. However, regular eye exams, good control of your blood sugar and blood pressure, and early
intervention for vision problems can help prevent severe vision loss.All diabetics should check their blood sugar
daily, see their doctor routinely, follow a diabetic diet, and have a dilated eye exam at least once a year.

References

Jack J. Kanski Klinicka Oftalmologija (2004) V izdanie ,datastatus -Beograd 445-454

K,Janev (2012) Opsta Oftalmologija -treto izdanie Skopje, 312-315

Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428-431. doi:10.4103/0301-4738.100542

Misita R. Vasilije dijabeticna retinopatija lecenje laserfotokoagulacijom , zavod za ucebnike I nastavna sredstva, Beograd (2000)

Sapra A, Bhandari P. Diabetes Mellitus. In: StatPearls. Treasure Island (FL): StatPearls Publishing; June 7, 2020

Kwan CC, Fawzi AA. Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy. Curr Diab Rep. 2019 Aug 31;19(10):95.

Diabetic retinopathy. National Eye Institute. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/diabetic-retinopathy. Accessed Feb. 19, 2021.

Brad H. Feldman, M.D., Vinay A. Shah M.D., Koushik Tripathy, MD (AIIMS), FRCS (Glasgow), Harkaran S. Rana D.O., Jason Hsu, MD, Jonathan C. Tsui, MD, Jennifer I Lim MD diabetic retinopaty June 11, 2022

Nevenka Laban Guceva (2020) Oftalmologija , Shtip 83-85

M. Mavija dijabeticka retinopatija I rizik faktorii ISBN 978-86-72244-978-5, Zaduzbina Andrejevic, Beograd (2011)

Kierstan Boyd Director of Patient Education, American Academy of Ophthalmology

-Present Diabetic retinopathy :cause ,sumptoms, tretman oct 27,2022

Downloads

Published

2022-12-16

How to Cite

Gazepov, S., Selimi Ademi, D., Grozdanova, E., Gjorgieva, B., & Shekerinov, T. (2022). DESCRIPTIVE STUDY OF NON-PROLIFERATIVE CORRELATED WITH PROLIFERATIVE DIABETIC RETINOPATHY IN CLINICAL HOSPITAL SHTIP. KNOWLEDGE - International Journal , 55(4), 643–647. Retrieved from https://ikm.mk/ojs/index.php/kij/article/view/5739

Most read articles by the same author(s)

<< < 1 2 3 4 5